News

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...
Neurizon’s open-label extension study of lead candidate NUZ-001 for amyotrophic lateral sclerosis reaches primary endpoint Study shows the drug at recommended phase II dose was safe and well-tolerated ...
Novo Nordisk NVO has secured European approval to update the label of oral GLP-1 drug for type II diabetes (T2D), Rybelsus ...
The strike comes after another military strike two weeks on what the Trump administration says was a drug-carrying speedboat ...
The date is Sept. 19, 1985, and Snider, 30, is in front of Congress to oppose adding warning labels to albums with explicit ...
First data on treatment of NPC1 with Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) in this age group over a period of 48 weeksAt 48 weeks of ...
When it comes to food safety, trust your senses. Look for changes in color or texture, smell for any sour or strange odors, ...
One of the nation's largest drug advertisers is likely working up major changes to its ad strategy in the wake of a federal government crackdown on drug TV commercials.
Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label.
The Trump administration is considering softening the classification of marijuana, from a Schedule I to a Schedule III drug. And this could have major implications for cannabis businesses in Chicago.
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label. The East Brunswick, New Jersey, company’s FDA-posted ...